Cited 0 times in Scipus Cited Count

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters

DC Field Value Language
dc.contributor.authorNahm, DH-
dc.contributor.authorAhn, A-
dc.contributor.authorKim, ME-
dc.contributor.authorCho, SM-
dc.contributor.authorPark, MJ-
dc.date.accessioned2018-05-04T00:23:57Z-
dc.date.available2018-05-04T00:23:57Z-
dc.date.issued2016-
dc.identifier.issn2092-7355-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/14781-
dc.description.abstractThis report evaluated long-term changes in clinical severity and laboratory parameters in 3 adult patients with severe recalcitrant atopic dermatitis (AD) who were treated with intramuscular injections of 50 mg of autologous immunoglobulin G (IgG) twice a week for 4 weeks (autologous immunoglobulin therapy, AIGT) and followed up for more than 2 years after the treatment. We observed the following 4 major findings in these 3 patients during the long-term follow-up after AIGT. (1) Two of the 3 patients showed a long-term clinical improvement for more than 36 weeks after AIGT with a maximum decrease in clinical severity score greater than 80% from baseline. (2) These 2 patients also showed long-term decreases in serum total IgE concentrations and peripheral blood eosinophil count for more than 36 weeks after AIGT with a maximum decrease in the two laboratory parameters of allergic inflammatory greater than 70% from baseline. (3) No significant side effect was observed during the 2 years of follow-up period after the AIGT in all 3 patients. (4) Serum levels of IgG anti-idiotype antibodies to the F(ab')(2) fragment of autologous IgG administered for the treatment were not significantly changed after AIGT in all 3 patients. These findings suggest that AIGT has long-term favorable effects on both clinical severity and laboratory parameters in selected patients with severe recalcitrant AD. Further studies are required to evaluate the clinical usefulness and therapeutic mechanism of AIGT for AD.-
dc.language.isoen-
dc.titleAutologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters-
dc.typeArticle-
dc.identifier.pmid27126731-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853515/-
dc.subject.keywordDermatitis-
dc.subject.keywordAtopic-
dc.subject.keywordAntibodies-
dc.subject.keywordImmunoglobulin G-
dc.subject.keywordImmunoglobulins-
dc.subject.keywordImmunomodulation-
dc.subject.keywordTherapy-
dc.contributor.affiliatedAuthor남, 동호-
dc.type.localJournal Papers-
dc.identifier.doi10.4168/aair.2016.8.4.375-
dc.citation.titleAllergy, asthma & immunology research-
dc.citation.volume8-
dc.citation.number4-
dc.citation.date2016-
dc.citation.startPage375-
dc.citation.endPage382-
dc.identifier.bibliographicCitationAllergy, asthma & immunology research, 8(4). : 375-382, 2016-
dc.identifier.eissn2092-7363-
dc.relation.journalidJ020927355-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Files in This Item:
27126731.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse